1 Li L-Q, Huang T, Wang Y-Q, Wang Z-P, Liang Y, Huang T-B, et al. COVID-19 patients` clinical characteristics, discharge rate, and fatality rate of meta-analysis. J Med Virol. 2020;92(6):577–83.
2 Carfi A, Bernabei R, Landi F. Persistent symptoms in patients after acute COVID-19. JAMA. 2020;324(6):603–5.
3 Coperchini F, Chiovato L, Rotondi M. Interleukin-6, CXCL10 and infiltrating macrophages in COVID-19-related cytokine storm: not one for all but all for one. Front Immunol. 2021;12:668507.
4 Hojyo S, Uchida M, Tanaka K, Hasebe R, Tanaka Y, Murakami M, et al. How COVID-19 induces cytokine storm with high mortality. Inflamm Regen. 2020;40:37.
5 Cho J, Nelson TE, Bajova H, Gruol DL. Chronic CXCL10 alters neuronal properties in rat hippocampal culture. J Neuroimmunol. 2009; 207(1-2):92–100.
6 Petrisko TJ, Bloemer J, Pinky PD, Srinivas S, Heslin RT, Du Y, et al. Neuronal CXCL10/CXCR3 axis mediates the induction of cerebral hyperexcitability by peripheral viral challenge. Front Neurosci. 2020;14:220.
7 Van Weering HRJ, Boddeke HWGM, Vinet J, Brouwer N, de Haas AH, van Rooijen A. CXCL10/CXCR3 signaling in glia cells differentially affects NMDA-induced cell death in CA and DG neurons of the mouse hippocampus. Hippocampus. 2011;21(2):220–32.
8 Satrom KM, Ennis K, Sweis BM, Matveeva TM, Chen J, Hanson L, et al. Neonatal hyperglycemia induces CXCL10/CXCR3 signaling and microglial activation and impairs long-term synaptogenesis in the hippocampus and alters behavior in rats. J Neuroinflammation. 2018;15(1):82.
9 Klein R, Soung A, Sissoko C, Nordvig A, Canoll P, Mariani M, et al. COVID-19 induces neuroinflammation and loss of hippocampal neurogenesis. Res Sq [Preprint]. 2021 Oct 29:rs.3.rs-1031824.
10 Valkanova V, Ebmeier KP, Allan CL. CRP, IL-6 and depression: a systematic review and meta-analysis of longitudinal studies. J Affect Disorder. 2013;150(3):736–44.
11 Douaud G, Lee S, Alfaro-Almagro F, Arthofer C, Wang C, McCarthy P, et al. SARS-CoV-2 is associated witjh changes in brain structure in UK Biobank. 2022;604(7907):697–7.
12 Vasilevska V, Steiner J. Inflammation und psychische Erkrankung. Info Neurologie +Psychiatrie. 2021;11:42–9.
13 Lu Y, Li X, Gend D, Mei N, Wu P-Y, Huang C-C, et al. Cerebral micro-structural changes in COVID-19 patients - an MRI-based 3-month follow-up study. EClinicalMedicine. 2020 Aug;25:100484.
14 Hogestol EA, Nygaard GO, Alnaes D, Beyer MK, Westlye LT, Harbo HF. Symptoms of fatigue and depression is reflected in altered default mode network connectivity in multiple sclerosis. PLoS One. 2019;14(4):e0210375.
15 Lefaucher J-P, Chala MA, Mhalla A, Palm U, Ayache SS, Mylius V. The treatment of fatigue by non-invasive bran stimulation. Neurophysiol Clin. 2017;47(2):173–84.
16 Ueyama E, Ukai S, Ogawa A, Yamamoto M, Kawaguchi Ishii R, et al. Chronic repetitive transcranial magnetic stimulation increases hippocampal neurogenesis in rats. Psychiatry Clin Neurosci. 2011;65(1):77–81.
17 Guo F, Lou J, Han X, Deng Y, Huang X. Repetitive transcranial magnetic stimulation ameliorates cognitive impairment by enhancing neurogenesis and suppressing apoptosis in the hippocampus in rats with ischemic stroke. Front Physiol. 2017;8:559.
18 Caulfield KA. Treating the mental health effects of COVID-19: The need for at-home neurotherapeutics is now. Brain Stimul. 2020;13(4):939–40.
19 Leichsenring F, Steinert C, Rabung S, Ioannidis JPA. The efficacy of psychotherapy and pharmacotherapy for mental disorders in adults: an umbrella review and meta-analytic evaluation of recent meta-analyses. World Psychiatry. 2022;21(1):133–45.